Summary : Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Diagnostics
-
-
Summary : The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however,…
-
AstraZenecaCompaniesMerck & CoRegulatoryU.S FDA
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
by adminby adminSummary : The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending…
-
Pharma Science & Research
Mutations leading to omicron variant did not enable virus to fully escape immune system
by adminby adminPeople who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19,…
-
Pharma Science & Research
Stealth nanomedicines combat cancer and cut toxic effects of chemo
by adminby adminSynopsis : Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery…
-
CompaniesPfizer
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
by adminby adminSummary : Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100%…
-
AbbVieCompaniesMerger / Acquisition
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
by adminby adminSummary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…
-
Summary : As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play.…
-
Summary – Takeda and Code Biotherapeutics announced a collaboration agreement to leverage the latter’s proprietary targeted 3DNA® non-viral genetic medicine delivery platform…
-
Global MarketMerger / Acquisition
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
by adminby adminSynopsis: Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and…